Assignment must be 250 to 350 words in length and supported with no more than two scholarly references within the last 5 years (cited in APA format).
Pharmacogenomics is a hot topic in healthcare and will continue to be with many companies working to develop complex gene therapies for rare diseases. Give an example of a pharmacogenetic test that health care provders can order to learn more about their patients. Do you believe this type of testing should be preemptive or reactive? Why or why not?